Journal of Radiation Research and Radiation Processing, Volume. 42, Issue 5, 050301(2024)
Non-invasive evaluation of epidermal growth factor receptor expression in gastric cancer animal models using 124I-labeled antibody and antibody fragment
Fig. 2. Quality control results for Cetuximab, Cet-F(ab')2 and Cet-Fab (M: protein marker; T: target protein)
Fig. 3. Immunofluorescence results of MGC803 cell line (×100) (BF: light field)
Fig. 4. Quality control and binding assays of 124I-Cetuximab, 124I-Cet-F(ab')2 and 124I-Cet-Fab: (a) iTLC results for 124I-Cetuximab; (b) iTLC results for 124I-Cet-F(ab')2; (c) iTLC results for 124I-Cet-Fab; (d) results of saturation experiments with 124I-Cetuximab; (e) results of saturation experiments for 124I-Cet-F(ab')2; (f) results of saturation experiments with 124I-Cet-Fab
Fig. 5. Micro-PET/CT imaging: (a) 124I-Cetuximab; (b) 124I-Cet-Fab; (c) 124I-Cet-F(ab')2; and biological distribution results:(d) 124I-Cetuximab; (e) 124I-Cet-Fab; (f) 124I-Cet-F(ab')2 (The dotted white line indicates the tumor) (color online)
Fig. 6. Immunohistochemistry and H&E staining of MGC803 tumor tissue
Get Citation
Copy Citation Text
Liming CHAI, Xiaolong YAO, Renhua NA, Wei YAN, Mingzheng JIANG, Canwen SUN, Zeqiang DAI, Haixu ZHU, Xiaofeng YANG. Non-invasive evaluation of epidermal growth factor receptor expression in gastric cancer animal models using 124I-labeled antibody and antibody fragment[J]. Journal of Radiation Research and Radiation Processing, 2024, 42(5): 050301
Category: RADIOBIOLOGY AND RADIOMEDICINE
Received: Jan. 26, 2024
Accepted: Mar. 17, 2024
Published Online: Jan. 2, 2025
The Author Email: YANG Xiaofeng (杨小丰)